Selegiline Hydrochloride
Overview
Selegiline Hydrochloride is a selective monoamine oxidase B (MAO-B) inhibitor primarily used in the treatment of Parkinson's disease. It may also be used in the treatment of major depressive disorder.
API suppliers (9)
Suppliers of Selegiline Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 9 suppliers.
2 of 9 hold a GMP certificate on record in the EU or UK registers
- Dipharma Francis SrlItaly1 active DMF GMP on record
- EUROAPI HUNGARY LTDHungary1 active DMF
- ALCHYMARS SPA
- Teva Pharmaceutical Industries Ltd.Israel GMP on record
- SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany
- IROTEC LABORATORIES
- Siegfried LTDUnited Kingdom
- RESOLUTION CHEMICALS LTD
- WYCKOFF CHEMICAL CO INC
Therapeutic areas
Do you supply Selegiline Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.